Literature DB >> 29878128

Ebola Virus Infection in Commonly Used Laboratory Mouse Strains.

Elaine Haddock1, Heinz Feldmann1, Andrea Marzi1.   

Abstract

The mouse model for Ebola virus (EBOV) is an established and often used animal model for countermeasure development. Although it has its limitations, it recapitulates certain key features of human EBOV disease and principally shows uniform lethality. However, in the recent past, several studies reported surviving animals when evaluating treatment or vaccine approaches. Therefore, we analyzed the severity of disease and lethality of mouse-adapted (MA-) EBOV infection in 6 different mouse strains. We identified outbred CD-1 mice to be the only strain tested resulting in uniform lethality when infected with different doses of MA-EBOV or reverse genetics-generated MA-EBOV. In contrast, infection of different inbred mouse strains resulted in partial survival depending on virus and dose. Of these inbred strains, 129 mice provided the most consistent model. Our study provides a helpful dataset when planning EBOV mouse studies for countermeasure efficacy testing and highlights the limitations of certain mouse strains as EBOV models.

Entities:  

Mesh:

Year:  2018        PMID: 29878128      PMCID: PMC6249562          DOI: 10.1093/infdis/jiy208

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice.

Authors:  A A Toye; J D Lippiat; P Proks; K Shimomura; L Bentley; A Hugill; V Mijat; M Goldsworthy; L Moir; A Haynes; J Quarterman; H C Freeman; F M Ashcroft; R D Cox
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

2.  Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.

Authors:  Andrea Marzi; Hideki Ebihara; Julie Callison; Allison Groseth; Kinola J Williams; Thomas W Geisbert; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

3.  A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.

Authors:  M Bray; K Davis; T Geisbert; C Schmaljohn; J Huggins
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

Review 4.  Post-exposure treatments for Ebola and Marburg virus infections.

Authors:  Robert W Cross; Chad E Mire; Heinz Feldmann; Thomas W Geisbert
Journal:  Nat Rev Drug Discov       Date:  2018-01-29       Impact factor: 84.694

5.  Cathepsin B & L are not required for ebola virus replication.

Authors:  Andrea Marzi; Thomas Reinheckel; Heinz Feldmann
Journal:  PLoS Negl Trop Dis       Date:  2012-12-06

6.  Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.

Authors:  Callie E Bounds; Steven A Kwilas; Ana I Kuehne; Jennifer M Brannan; Russell R Bakken; John M Dye; Jay W Hooper; Lesley C Dupuy; Barry Ellefsen; Drew Hannaman; Hua Wu; Jin-an Jiao; Eddie J Sullivan; Connie S Schmaljohn
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

7.  In vivo Ebola virus infection leads to a strong innate response in circulating immune cells.

Authors:  Ignacio S Caballero; Anna N Honko; Stephen K Gire; Sarah M Winnicki; Marta Melé; Chiara Gerhardinger; Aaron E Lin; John L Rinn; Pardis C Sabeti; Lisa E Hensley; John H Connor
Journal:  BMC Genomics       Date:  2016-09-05       Impact factor: 3.969

Review 8.  Use of C57BL/6N mice on the variety of immunological researches.

Authors:  Hyun Keun Song; Dae Youn Hwang
Journal:  Lab Anim Res       Date:  2017-06-30

Review 9.  Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo.

Authors:  L Roux; A E Simon; J J Holland
Journal:  Adv Virus Res       Date:  1991       Impact factor: 9.937

Review 10.  Mouse models for filovirus infections.

Authors:  Steven B Bradfute; Kelly L Warfield; Mike Bray
Journal:  Viruses       Date:  2012-09-07       Impact factor: 5.048

View more
  8 in total

1.  CD47 expression attenuates Ebola virus-induced immunopathology in mice.

Authors:  Deepashri Rao; Kyle L O'Donnell; Aaron Carmody; Irving L Weissman; Kim J Hasenkrug; Andrea Marzi
Journal:  Antiviral Res       Date:  2021-12-17       Impact factor: 5.970

2.  Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera.

Authors:  Raveen Rathnasinghe; Sonia Jangra; Chengjin Ye; Anastasija Cupic; Gagandeep Singh; Carles Martínez-Romero; Lubbertus C F Mulder; Thomas Kehrer; Soner Yildiz; Angela Choi; Stephen T Yeung; Ignacio Mena; Virginia Gillespie; Jana De Vrieze; Sadaf Aslam; Daniel Stadlbauer; David A Meekins; Chester D McDowell; Velmurugan Balaraman; Michael J Corley; Juergen A Richt; Bruno G De Geest; Lisa Miorin; Florian Krammer; Luis Martinez-Sobrido; Viviana Simon; Adolfo García-Sastre; Michael Schotsaert
Journal:  Nat Commun       Date:  2022-07-07       Impact factor: 17.694

3.  Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model.

Authors:  Richard S Bennett; James Logue; David X Liu; Rebecca J Reeder; Krisztina B Janosko; Donna L Perry; Timothy K Cooper; Russell Byrum; Danny Ragland; Marisa St Claire; Ricky Adams; Tracey L Burdette; Tyler M Brady; Kyra Hadley; M Colin Waters; Rebecca Shim; William Dowling; Jing Qin; Ian Crozier; Peter B Jahrling; Lisa E Hensley
Journal:  Viruses       Date:  2020-07-14       Impact factor: 5.048

4.  Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.

Authors:  Jason E Comer; Olivier Escaffre; Natasha Neef; Trevor Brasel; Terry L Juelich; Jennifer K Smith; Jeanon Smith; Birte Kalveram; David D Perez; Shane Massey; Lihong Zhang; Alexander N Freiberg
Journal:  Viruses       Date:  2019-02-03       Impact factor: 5.048

5.  Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.

Authors:  David W Hawman; Kimberly Meade-White; Shanna Leventhal; Friederike Feldmann; Atsushi Okumura; Brian Smith; Dana Scott; Heinz Feldmann
Journal:  Elife       Date:  2021-01-08       Impact factor: 8.140

6.  Ebola Virus Glycoprotein Domains Associated with Protective Efficacy.

Authors:  Bharti Bhatia; Wakako Furuyama; Thomas Hoenen; Heinz Feldmann; Andrea Marzi
Journal:  Vaccines (Basel)       Date:  2021-06-10

7.  A VSV-based Zika virus vaccine protects mice from lethal challenge.

Authors:  Jackson Emanuel; Julie Callison; Kimberly A Dowd; Theodore C Pierson; Heinz Feldmann; Andrea Marzi
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

Review 8.  Pathogen Dose in Animal Models of Hemorrhagic Fever Virus Infections and the Potential Impact on Studies of the Immune Response.

Authors:  Bryce M Warner
Journal:  Pathogens       Date:  2021-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.